Harvard Bioscience Inc (FRA:HBI0)

Q4 2024 Harvard Bioscience Inc Earnings Call Transcript

Mar 12, 2025 / 12:00PM GMT

Release Date Price: €5.85 (-16.43%)

Transcript 10-K8-K

Key Points

Positve

Sequential revenue improvement in Q4 2024, with a 12% increase from Q3.
Positive book-to-bill ratio indicating strong demand.
Successful launch and adoption of new products like the SoHo telemetry devices and MeshMEA systems.
Expansion of distribution agreements with major distributors like Fisher and VWR to include North America.
Strong growth in European revenues due to new product introductions.

Negative

Q4 2024 revenue was 13% below the same quarter last year.
Operating income was break-even on a GAAP basis.
Non-compliance with the net leverage ratio covenant in the existing credit agreement.
Significant decline in APAC revenue, down 24% compared to the prior year.
Uncertainty around NIH funding affecting visibility and future revenue projections.

Operator

Good day and welcome to the fourth quarter of 2024 Harvard Bioscience earnings conference call. (Operator instructions) This call may be recorded.

I would like to turn the call over to Kathryn Flynn, corporate controller.

Kathryn Flynn

Harvard Bioscience Inc - Corporate Controller

Thank you, Michelle, and good morning everyone.

Thank you for joining the Harvard Bioscience fourth quarter 2024 earnings conference call. Leading the call today will be Jim Green, President and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer. In conjunction with today's recorded call, we have provided a presentation that will be referenced during our remarks that is posted to the investor section of our website at investor.harvardbioscience.com.

Please note that statements made in today's discussion that are not historical facts, including statements or expectations or future events or future financial performance, are forward-looking statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.